ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LUPRON DEPOT-PED 3 MONTH
Pituitary disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LUPRON DEPOT-PED 3 MONTH Rx

Generic Name and Formulations:
Leuprolide acetate 11.25mg, 30mg; per kit; depot susp for IM inj; preservative-free.

Company:
AbbVie

Therapeutic Use:

Indications for LUPRON DEPOT-PED 3 MONTH:

Central precocious puberty.

Adult:

Not applicable.

Children:

<2yrs: not recommended. ≥2yrs: 11.25mg or 30mg as a single IM inj once every 3 months. If inadequate response, consider other alternative treatments.

Contraindications:

Pregnancy (Cat.X).

Warnings/Precautions:

Confirm diagnosis. Monitor for psychiatric symptoms. History of seizures/epilepsy, cerebrovascular disorders, CNS anomalies or tumors: risk of convulsions. Monitor hormonal effects after 1–2 months of starting therapy, with dose changes and during treatment. Depot 3-Month: monitor at months 2–3, month 6 and as needed thereafter. Measure height and bone age velocity every 6–12 months. Exclude pregnancy before treatment. Nursing mothers: not recommended.

Interactions:

Caution with concomitant drugs that are associated with convulsions (eg, bupropion, SSRIs).

See Also:

LUPRON DEPOT-PED

Pharmacological Class:

GnRH analogue.

Adverse Reactions:

Transient exacerbation of symptoms, inj site reactions, pain, headache, emotional lability, hot flushes/sweating, acne/seborrhea, rash, vaginitis, vaginal discharge, syncope, GI upset, gynecomastia, weight increased, mood altered; convulsions.

How Supplied:

Depot-PED kit—1 (prefilled dual-chamber syringe w. diluent); Depot-PED 3 Month kit—1 (prefilled dual-chamber syringe w. diluent)

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs